Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides

Current Biology : CB
N HevekerJ Schneider-Mergener

Abstract

The chemokine receptor CXCR4 (a receptor for the Cys-X-Cys class of chemokines) is a CD4-associated coreceptor for T-cell-tropic strains of human immunodeficiency virus 1 (HIV-1) and represents a target for antiviral therapy. Infection by T-tropic HIV-1 can be blocked by stromal-cell-derived factor-1 (SDF-1), the natural ligand of CXCR4. The broad variety of cells expressing CXCR4 and the perturbations observed in mice deficient for SDF-1 suggest that antiviral compounds antagonizing the signalling activity of CXCR4 might have severe side effects in vivo. Compounds that interfere selectively with HIV entry and not with SDF-1 signalling would therefore be useful. A series of peptides, each of 13 residues, spanning the whole SDF-1alpha sequence were tested for their ability to block HIV-1 infection. The antiviral and signalling properties of SDF-1 were retained by a peptide corresponding to its amino terminus. Removal of the first two residues resulted in an antiviral antagonist of the SDF-1-CXCR4 signalling pathway. We prepared 234 single-substitution analogues and identified one antiviral analogue that had drastically reduced agonistic or antagonistic properties. The antiviral peptides competed with the monoclonal antibody 12G5...Continue Reading

References

Aug 1, 1994·Immunological Reviews·F MiedemaP T Schellekens
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·S J SicilianoM S Springer
Jun 4, 1993·Science·M GroeninkH Schuitemaker
Oct 3, 1996·Nature·F Arenzana-SeisdedosM Baggiolini
Aug 1, 1997·Current Opinion in Immunology·J P MooreT Dragic
Oct 23, 1997·The Journal of Experimental Medicine·D ScholsE De Clercq
Oct 23, 1997·The Journal of Experimental Medicine·T MurakamiT Nagasawa

❮ Previous
Next ❯

Citations

Aug 27, 2013·Biochemical Pharmacology·Anna EhrlichGary D Luker
Apr 6, 2004·Trends in Pharmacological Sciences·Terry Kenakin
Apr 28, 2001·Cytokine & Growth Factor Reviews·T S Stantchev, C C Broder
Nov 17, 2011·Journal of Medicinal Chemistry·Won-Tak ChoiJing An
Oct 26, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·A KramerJ Schneider-Mergener
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·E G CormierT Dragic
Jan 31, 2002·AIDS·A Brelot, M Alizon
Jul 10, 1999·Immunological Reviews·A Pelchen-MatthewsM Marsh
Sep 19, 2008·Science Signaling·Christopher T VeldkampBrian F Volkman
Sep 29, 2004·Journal of Virology·Ming-Bo HuangVincent C Bond
Jun 8, 2001·Annual Review of Biochemistry·D M Eckert, P S Kim
Jun 8, 1999·Annual Review of Immunology·E A BergerJ M Farber
May 14, 2011·Experimental Biology and Medicine·Won-Tak Choi, Jing An
Jan 31, 2012·Expert Opinion on Investigational Drugs·Amnon PeledJan Burger
Aug 10, 2011·Biochemical Pharmacology·Andy ChevignéSabrina Deroo
Apr 16, 2008·Biochimica Et Biophysica Acta·Aviva LapidotGadi Borkow
Jun 30, 2009·The Journal of Gene Medicine·Anna EgorovaArto Urtti
Jul 16, 2008·Chemical Biology & Drug Design·Xiangyang Liang
Oct 13, 2012·The Prostate·Manisha AgarwalJill A Macoska
Sep 19, 2006·Seminars in Immunology·Fernando Arenzana-Seisdedos, Marc Parmentier
Jul 18, 2001·The Journal of General Virology·T Dragic
Apr 2, 2003·Virology·Naiming ZhouRoger J Pomerantz
Jul 20, 2016·Journal of Medicinal Chemistry·Christine E MonaEmanuel Escher
Dec 7, 2007·Biotechnology & Genetic Engineering Reviews·Kai HilperRobert E W Hancock
Oct 3, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yanqing LiuHualiang Jiang
Jan 1, 2004·The Journal of Biological Chemistry·Valérie WittamerMarc Parmentier
Aug 14, 1999·The Journal of Biological Chemistry·S A AliA Steinkasserer
Nov 3, 2016·Organic & Biomolecular Chemistry·Christine E MonaEmanuel Escher
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·J P Moore, M Stevenson
Jan 27, 2006·The EMBO Journal·Paolo Lusso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.